reports
Centessa Pharmaceuticals Reports Financial Results and Business Highli...
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024 Hemophilia Program: Ongoing registrational PRESent-2 and PRESent-3 studies of SerpinPC for the treatment of hemophilia B; PRESent-2 interim analysis planned in 2024Orexin Agonist Program: Cleared IND and initiated Phase 1 first-in-human clinical trial of ORX750, a highly potent and selective OX2R agonist for the treatment of narcolepsy; Clinical proof-of-concept data in acutely sleep-deprived healthy volunteers planned in 2H of 2024LockBody® Technology Platform: Ongoing Phase 1/2a study ...
TeraWulf Reports First Quarter 2024 Financial Results
TeraWulf Reports First Quarter 2024 Financial Results Self-mined 1,057 bitcoin in Q1 2024, an 8.9% increase over Q4 2023, on a total installed hashrate of 8.0 EH/s. Q1 2024 revenue grows 82.2% over Q4 2023 to $42.4 million. Q1 2024 Non-GAAP Adjusted EBITDA increases 95.4% over Q4 2023 to $32.0 million. Paid down approximately $63.6 million of debt so far in 2024, demonstrating the power of low-cost, profitable operations. On track to reach ~10.2 EH/s in Q3 2024, with plans to grow to ~13.3 EH/s by Q1 2025. EASTON, Md., May 13, 2024 (GLOBE NEWSWIRE) -- TeraWulf Inc. (Nasdaq...
TMC Announces First Quarter 2024 Results
TMC Announces First Quarter 2024 Results NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), an explorer of lower-impact battery metals from seafloor polymetallic nodules, today provided a corporate update and first quarter financial results for the period ending March 31, 2024. Q1 2024 Financial Highlights $11.9 million cash used in operations for the quarter ended March 31, 2024Net loss of $25.2 million and net loss per share of $0.08 for the quarter ended March 31, 2024Total liquidity of approximately $49 million at March 31,...
Infinera Corporation Fourth Quarter and Fiscal 2023 Summary of Key Fin...
Infinera Corporation Fourth Quarter and Fiscal 2023 Summary of Key Financial Results SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Infinera Corporation (NASDAQ: INFN) has issued a press release with a summary of key financial results for the fourth quarter and fiscal year ended December 30, 2023. The press release is also published on Infinera’s Investor Relations website. GAAP revenue for the quarter was $453.5 million compared to $392.4 million in the third quarter of 2023 and $485.9 million in the fourth quarter of 2022. GAAP gross margin for the quarter was 38.6% compared to 40...
Urgently Announces First Quarter 2024 Financial Results
Urgently Announces First Quarter 2024 Financial Results First Quarter Performance Reflects Continued Margin Expansion VIENNA, Va., May 13, 2024 (GLOBE NEWSWIRE) -- Urgent.ly Inc. (Nasdaq: ) (“Urgently”), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, today reported financial results for the first quarter ended March 31, 2024. “Our first quarter financial performance was in line with our expectations. We made continued progress with our strategic initiatives to drive gross margin expansion through operational efficiencies and disciplin...
PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healt...
PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 2024 Leerink Partners Healthcare Crossroads Conference in Austin, Texas. Management is scheduled to present on Wednesday, May 29 at 10:20 a.m. Eastern Tim...
GitLab To Announce First Quarter Fiscal 2025 Financial Results
GitLab To Announce First Quarter Fiscal 2025 Financial Results SAN FRANCISCO, May 13, 2024 (GLOBE NEWSWIRE) -- All Remote - GitLab Inc., (NASDAQ: GTLB), the most comprehensive AI-powered DevSecOps Platform, today announced that it will report its financial results for the first quarter of fiscal year 2025, which ended April 30, 2024, after U.S. markets close on Monday, June 3, 2024. Management will host a conference call and webcast on the same day to discuss the company’s financial results at 4:30 p.m. EST / 1:30 p.m. PST. GitLab First Quarter Fiscal 2025 Financial Results Conference Ca...
Hyperfine, Inc. Reports First Quarter 2024 Financial Results
Hyperfine, Inc. Reports First Quarter 2024 Financial Results GUILFORD, Conn., May 13, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2024 financial results and provided a business update. “We have kicked off 2024 strong. I am pleased with our commercial progress shown by sales across US and international accounts, as well as the important milestones we hit in Q1 by commencin...
Capricor Therapeutics Reports First Quarter 2024 Financial Results and...
Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update –Phase 3, HOPE-3 Trial (Cohort A) of CAP-1002 in Duchenne Muscular Dystrophy Fully Enrolled; On Track to Report Top-Line Data in Q4 2024– –Positive Type-B CMC FDA Meeting held in Q1; Company Aligned with FDA on Demonstration of Non-Clinical Comparability, A Major Milestone on Path to CMC Clearance for BLA– –Received First Milestone Payment of $10 Million under U.S. Distribution and Commercialization Agreement with Nippon Shinyaku in Q1– –Recent FDA Feedback Supports Requests for a Pre-BLA Mee...
Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial...
Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results Company to host call at 4:30pm today NEWTOWN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced results for the quarter ended March 31, 2024. First Quarter and Recent Business Updates Received Healthcare Common Procedure Coding System (“HCPCS”) codes and preliminary determination for reimbursement for the Portab...
Earlyworks Announces Plan to Implement ADS Ratio Change
Earlyworks Announces Plan to Implement ADS Ratio Change TOKYO, May 13, 2024 (GLOBE NEWSWIRE) -- Earlyworks Co., Ltd. (Nasdaq: ELWS) (the “Company” or “Earlyworks”), a Japanese company operating its proprietary private blockchain technology, Grid Ledger System (“GLS”), announced plans to change the ratio of its American Depository Shares (“ADSs”) to its ordinary shares from one (1) ADS, representing one (1) ordinary share, to one (1) ADS representing five (5) ordinary shares (the “ADS Ratio”). The change in the ADS Ratio is expected to become effective on or about May 16, 2024 (the “Effect...
Navitas Semiconductor to Participate in Upcoming Investor Events
Navitas Semiconductor to Participate in Upcoming Investor Events Executives to review drivers of $1.6B pipeline and mission to “Electrify Our World™” TORRANCE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- , the only pure-play, next-generation power semiconductor company and industry leader in GaNFast™ gallium nitride (GaN) power ICs and GeneSiC™ silicon carbide (SiC) technology, has announced participation in the following upcoming investor events: MESH Ventures Call May 14th: 7pm Pacific, 10pm Eastern US / May 15th 10am Taipei / Hong KongGroup call with Gene Sheridan, CEO, and Janet Chou...
Cardiff Oncology to Present at Upcoming Investor Conferences in May
Cardiff Oncology to Present at Upcoming Investor Conferences in May SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that company management will present at two upcoming investor conferences in May 2024. Details of the presentations can be found below. H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQLocation: The Nasdaq Headquarters, New York CityPresenter: Mark Erlander, CEOFormat: Fireside ChatDate:...
RxSight, Inc. Announces Closing of its Public Offering of Common Stock...
RxSight, Inc. Announces Closing of its Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares ALISO VIEJO, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc. (Nasdaq: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it has closed its underwritten public offering of 2,053,571 shares of its common stock, at a price to the public of $56.00 per share, which includes the full exercise by the underwriters of their option to purchase u...
scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConn...
scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference BURLINGTON, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, will present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference, which will be held at the NASDAQ World Headquarters in New Yor...
Moody's Ratings downgrades to A2 from A1 LOC-backed variable rate dem...
Moody's Ratings (Moody's) has downgraded the long-term ratings of the below bonds to A2 from A1. The ratings were previously on review for downgrade. Moody's reviewed the long-term rating of the bonds following Moody's rating action of Truist Bank (the Bank). On May 8, 2024, Moody's downgraded the ...
Banzai Continues Strong Organic Growth with the Addition of Over 230 C...
Banzai Continues Strong Organic Growth with the Addition of Over 230 Customers in April Customer Wins and Reactivations Momentum Carries Over into Q2 Signaling Continuous Demand SEATTLE, May 13, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and sales solutions, today celebrates the Company’s successful and continuous customer acquisitions efforts with the addition of 169 new and 62 reactivating customers during April 2024. Banzai previously added over 580 customers in Q1 2024, bringing the t...
Espey Mfg. & Electronics Corp. reports third quarter results
Espey Mfg. & Electronics Corp. reports third quarter results SARATOGA SPRINGS, N.Y., May 13, 2024 (GLOBE NEWSWIRE) -- Espey Mfg. & Electronics Corp. (NYSE American: ESP) announces results for the third quarter and the first nine months of fiscal year 2024. Net sales for the third quarter of fiscal year 2024, January 1 to March 31, 2024, were $8,254,653 compared with last year's third quarter net sales of $9,809,616. Net income for the quarter was $1,031,930, $0.40 per diluted share, as compared to net income of $867,288, $0.35 per diluted share for the same quarter last year. For th...
Highwoods Publishes 2023 Corporate Resiliency Report
Highwoods Publishes 2023 Corporate Resiliency Report RALEIGH, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE: HIW) has published its 2023 Corporate Resiliency Report, which highlights the Company’s Environmental, Social and Governance initiatives. A copy of the report can be accessed by clicking on the link below and on the Company’s website at /sustainability. In 2023, our continued efforts to advance our ESG and resiliency strategy have earned us: GRESB: A Green Star rating for the fourth consecutive year and continued year-over-year performance improv...
CompoSecure Chief Product & Innovation Officer to Speak at Seamless Mi...
CompoSecure Chief Product & Innovation Officer to Speak at Seamless Middle East 2024 Adam Lowe will discuss the importance of easy-to-use security solutions to help fight fraud DUBAI, United Arab Emirates, May 13, 2024 (GLOBE NEWSWIRE) -- Dubai — May 13, 2024 — (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced Chief Product and Innovation Officer, Dr. Adam Lowe, will be delivering key presentations at , focusing on security innovations, including the company’s Arculus Authenticate® and Cold Storage technology, that enhances customer...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.